Planta Med 2001; 67(6): 533-537
DOI: 10.1055/s-2001-16488
Original Paper
Pharmacology
© Georg Thieme Verlag Stuttgart · New York

Neurotrophic and Neuroprotective Actions of Ginsenosides Rb1 and Rg1

Myra Rudakewich, Fang Ba, Christina G. Benishin
  • Department of Physiology, Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada
Further Information

Publication History

September 18, 2000

December 15, 2000

Publication Date:
17 August 2001 (online)

Abstract

The ginsenosides have many pharmacological actions, including various actions on the nervous system. Our previous studies have demonstrated that two ginsenosides, Rb1 and Rg1 improve performance in a passive avoidance-learning paradigm and enhance cholinergic metabolism. The present study was designed to examine the cellular neurotrophic and neuroprotective actions of two pure ginsenosides in two model systems. PC12 cells were grown in the absence or presence of nerve growth factor (NGF) as a positive control, and different concentrations of Rb1 or Rg1. To assess neurotrophic properties, neurite outgrowth was quantified for representative fields of cells. After 8 days in culture, both ginsenosides enhanced neurite outgrowth in the presence of a sub-optimal dose of (2 ng/ml) NGF, but did not significantly stimulate neurite outgrowth in the absence of NGF. However, after 18 days in culture, both ginsenosides increased neurite outgrowth in the absence of NGF. SN-K-SH cells were grown in the absence or presence of MPTP or β-amyloid to assess neuroprotection. Rb1 and Rg1 both reversed MPTP-induced cell death. β-Amyloid-induced cell death was not reversed by either ginsenoside, but Rg1 produced a modest enhancement of cell death in this model. These results suggest that these two ginsenosides have neurotrophic and selective neuroprotective actions that may contribute to the purported enhancement of cognitive function.

References

  • 1 Saito H. Effects of ginsenoside Rb1 and ginsenosides Rg1 on learning and memory. In: Shibata S, Ohtsuka Y, Saito H, editors Recent Advances in Ginseng Studies. Tokyo; Hirokawa Publishing Co 1990: 99-111
  • 2 Benishin C G, Lee R, Wang L C, Liu H J. Effects of ginsenoside Rb1 on central cholinergic metabolism.  Pharmacology. 1991;  42 224-9
  • 3 Sloley B D, Pang P KT, Huang B H, Ba F, Li F L, Benishin C G, Greenshaw A J, Shan J J. American ginseng extract reduces scopolamine-induced amnesia in a spatial learning task.  Journal of Psychiatry & Neuroscience. 1999;  24 442-52
  • 4 Benishin C G. Actions of ginsenoside Rb1 on choline uptake in central cholinergic nerve endings.  Neurochemistry International. 1992;  21 1-5
  • 5 Itoh T, Zang Y, Murai S, Saito H. Effects of Panax ginseng root on the vertical and horizontal motor activities and on brain monoamine-related substance in mice.  Planta Medica. 1989;  5 429-33
  • 6 D’Angelo L, Grimaldi R, Caravaggi M, Marcoli M, Perucca E, Lecchini S, Frigo G M, Crema A. A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers.  Journal of Ethnopharmacology. 1986;  16 15-22
  • 7 Abe K, Cho S I, Kitagawa I, Nishiyama N, Saito H. Differential effects of ginsenoside Rb1 and malonylginsenoside Rb1 on long-term potentiation in the dentate gyrus of rats.  Brain Research. 1996;  649 7-11
  • 8 Nishiyama N, Cho S I, Kitagama I, Saito H. Malonylginsenoside Rb1 potentiates nerve growth factor (NGF)-induced neurite outgrowth of cultured chick embryonic dorsal root ganglia.  Biological and Pharmaceutical Bulletin. 1994;  17 509-13
  • 9 Nishiyama N. Effects of ginseng saponins on cultured neuron cells. In: Shibata S, Ohtsuka Y, Saito H, editors Recent Advances in Ginseng Studies. Tokyo; Hirokawa Publishing Co 1990: 125-37
  • 10 Coleman E S, Wooten M W. Nerve growth factor-induced differentiation of PC12 cells employs the PMA-insensitive protein kinase C-zeta isoform.  Journal of Molecular Neuroscience. 1994;  5 39-57
  • 11 Kenarova B, Neychev H, Hadjiivanova C, Petkov V. Immunomodulating activity of ginsenoside Rg1 from Panax ginseng .  Japanese Journal of Pharmacology. 1990;  54 447-54
  • 12 Matsuda H, Samukawa K, Kubo M. Anti-inflammatory activity of ginsenoside Ro.  Planta Medica. 1990;  56 19-23
  • 13 Deng H, Zhang J. Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1.  Chinese Medical Journal. 1991;  104 395-8
  • 14 Kang S Y, Schini-Kerth V B, Kim N D. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta.  Life Sciences. 1995;  56 1577-86
  • 15 Hartikka J, Hefti F. Comparison of nerve growth factor’s effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro .  Journal of Neuroscience Research. 1988;  21 352-64
  • 16 Szeberenyi J, Erhardt P. Cellular components of nerve growth factor signaling.  Biochimica et Biopyhsica Acta. 1994;  1222 187-202
  • 17 Rabin S J, Mocchetti I. GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA.  Journal of Neurochemistry. 1995;  65 347-54
  • 18 Traina G, Petrucci C, Gargini C, Bagnoli P. Somatostatin enhances neurite outgrowth in PC12 cells.  Developmental Brain Research. 1998;  111 223-30
  • 19 Przedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity.  Movement Disorders. 1998;  13 35-8
  • 20 Ba F, Pang P KT, Benishin C G. The neuroprotective effects of estrogen in SK-N-SH culture and the possible mechanisms.  Society for Neuroscience Abstracts. 2000;  26 325
  • 21 Arispe N, Pollard B H, Rojas E. beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease.  Molecular and Cellular Biochemistry. 1994;  140 119-25

Dr. Christina G. Benishin

Department of Physiology

University of Alberta

Edmonton

Alberta

Canada

Fax: 780-492-1237

Email: christina.benishin@ualberta.ca

Phone: Tel. 780-492-5284

    >